New perspectives in glutamate and anxiety.

  title={New perspectives in glutamate and anxiety.},
  author={Carlos Riaza Bermudo-Soriano and M. Mercedes Perez-Rodriguez and Concepci{\'o}n Vaquero-Lorenzo and Enrique Baca-Garc{\'i}a},
  journal={Pharmacology, biochemistry, and behavior},
  volume={100 4},
Anxiety and stress-related disorders, namely posttraumatic stress disorder (PTSD), generalized anxiety disorder (GAD), obsessive-compulsive disorder (ODC), social and specific phobias, and panic disorder, are a major public health issue. A growing body of evidence suggests that glutamatergic neurotransmission may be involved in the biological mechanisms underlying stress response and anxiety-related disorders. The glutamatergic system mediates the acquisition and extinction of fear-conditioning… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 60 extracted citations


Publications referenced by this paper.
Showing 1-10 of 379 references

Allosteric Modulators for mGlu Receptors

Current neuropharmacology • 2007
View 11 Excerpts
Highly Influenced

Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.

European journal of pharmacology • 2005
View 13 Excerpts
Highly Influenced

The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society • 2004
View 12 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…